223 related articles for article (PubMed ID: 6196789)
41. Interferon therapy--molecular mechanisms and clinical applications. Proceedings of a satellite symposium held at the 4th European Conference on Clinical Oncology and Cancer Nursing. Madrid, Spain, 1st-4th November 1987.
Br J Clin Pract Suppl; 1988 Mar; 62():1-26. PubMed ID: 2462897
[No Abstract] [Full Text] [Related]
42. [On the use and mechanisms of action of Interferon as antitumour substances (author's transl)].
Busse E; Rose H; Flöth L
Radiobiol Radiother (Berl); 1980 Feb; 21(1):18-22. PubMed ID: 6162170
[No Abstract] [Full Text] [Related]
43. Clinical and immunological studies of human fibroblast interferon.
Ezaki K; Ogawa M; Okabe K; Abe K; Inoue K; Horikoshi N; Inagaki J
Cancer Chemother Pharmacol; 1982; 8(1):47-55. PubMed ID: 6178525
[No Abstract] [Full Text] [Related]
44. Interferon to fight cancer.
Roy S
J Indian Med Assoc; 1980 Oct; 75(7):147-8. PubMed ID: 6165778
[No Abstract] [Full Text] [Related]
45. Potential mechanisms of interferon neurotoxicity.
Bender CM; Monti EJ; Kerr ME
Cancer Pract; 1996; 4(1):35-9. PubMed ID: 8788769
[TBL] [Abstract][Full Text] [Related]
46. Approaches to the immunological monitoring of cancer patients treated with natural or recombinant interferons.
Herberman RB; Thurman GB
J Biol Response Mod; 1983; 2(6):548-62. PubMed ID: 6198476
[No Abstract] [Full Text] [Related]
47. [Interferon in cancer--belief, hope and reality].
Strander H; Einhorn S
Lakartidningen; 1980 Aug; 77(32-33):2673-5. PubMed ID: 6161282
[No Abstract] [Full Text] [Related]
48. [Nursing care of a patient with interferon therapy].
Bätzing R
Krankenpflege (Frankf); 1989 Jun; 43(6):289. PubMed ID: 2473247
[No Abstract] [Full Text] [Related]
49. Interferon, an antiviral drug for use in man.
Myers M; Galasso G
Tex Rep Biol Med; 1981-1982; 41():543-8. PubMed ID: 6189221
[No Abstract] [Full Text] [Related]
50. Human leukocyte interferon in the treatment of selected cancer patients.
Peddinani MV; Savery F
Clin Ther; 1983; 5(4):336-41. PubMed ID: 6871918
[TBL] [Abstract][Full Text] [Related]
51. The interferons--Part 1.
Freeman PR
Am Pharm; 1994 May; NS34(5):24-6. PubMed ID: 7518644
[No Abstract] [Full Text] [Related]
52. [The interferon system].
Tăriceanu V
Viata Med Rev Inf Prof Stiint Cadrelor Medii Sanit; 1987 Dec; 35(12):265-70. PubMed ID: 2471349
[No Abstract] [Full Text] [Related]
53. Gene therapy of cancer with interferon: lessons from tumor models and perspectives for clinical applications.
Ferrantini M; Belardelli F
Semin Cancer Biol; 2000 Apr; 10(2):145-57. PubMed ID: 10936064
[TBL] [Abstract][Full Text] [Related]
54. Interferons, immunity and cancer immunoediting.
Dunn GP; Koebel CM; Schreiber RD
Nat Rev Immunol; 2006 Nov; 6(11):836-48. PubMed ID: 17063185
[TBL] [Abstract][Full Text] [Related]
55. Neuropsychiatric complications of interferons: classification, neurochemical bases, and management.
Malek-Ahmadi P; Hilsabeck RC
Ann Clin Psychiatry; 2007; 19(2):113-23. PubMed ID: 17612851
[TBL] [Abstract][Full Text] [Related]
56. The natural killer cell-interferon system in human carcinoma--its relation to interferon cancer treatment trials.
Ching NP; Ching CY; Jim EL; Loh KK; Oishi N; Yim DW
Hawaii Med J; 1984 Oct; 43(10):368-72. PubMed ID: 6210268
[No Abstract] [Full Text] [Related]
57. Interferon and malignant disease.
Sikora K
Br J Clin Pract; 1986 Oct; 40(10):406-10. PubMed ID: 2443152
[No Abstract] [Full Text] [Related]
58. Interferon: reason for hope.
Warren B
Can Nurse; 1983 Feb; 79(2):15-6. PubMed ID: 6186360
[No Abstract] [Full Text] [Related]
59. Cryosurgery and immunotherapy for prostatic cancer.
Loening S; Lubaroff D
Urol Clin North Am; 1984 May; 11(2):327-36. PubMed ID: 6203207
[TBL] [Abstract][Full Text] [Related]
60. The interferon-cancer trials: hardly hopeless but not too heartening.
Hager T
JAMA; 1983 Aug; 250(8):1007-10. PubMed ID: 6192259
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
